Here’s whether Eli Lilly & Co. (LLY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.34% over 10 days); strong 1-year return of +47.8%; 3-month momentum positive (+12.2%). Concerns: RSI 72 — overbought, elevated pullback risk. Currently 3.0% off its 52-week high. Score: +5/7.
LLY is in a confirmed uptrend, trading above both its 50-day ($973.02) and 200-day ($947.62) moving averages. With an RSI of 71.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +47.8% compares to +24.4% for SPY (beat the market by 23.4%).
$10,000 invested 1 year ago→ $14,777 today
vs. S&P 500 (SPY) — same period beat market by 23.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($947.62)
✓Above 50-day MA ($973.02)
!RSI(14) neutral zone (30–70) — currently 71.7
✓Positive return (+47.8%)
✓Within 10% of period high (−3.0%)
Period Range $1,131.42
$623.78$1,166.29
RSI (14) 71.7
0 · OversoldOverbought · 100
Key Metrics
Price$1,131.42
Period Return+47.8%
Period High$1,166.29
Period Low$623.78
Drawdown−3.0%
MA-50$973.02
MA-200$947.62
RSI (14)71.7
Avg Volume (30d)3.5M
vs. SPYbeat by 23.4%
Return Rank#362 of 1245
Trend Signals
Price is above the 200-day moving average ($947.62)
Price is above the 50-day moving average ($973.02)